世界の筋弛緩剤市場2023年:企業・地域・タイプ・用途別分析

【英語タイトル】Global Muscle Relaxant Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料(GIR23AG11474)・商品コード:GIR23AG11474
・発行会社(調査会社):GlobalInfoResearch
・発行日:2023年8月
・ページ数:114
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(注文後2-3日)
・調査対象地域:グローバル
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の筋弛緩剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の筋弛緩剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 筋弛緩剤の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

筋弛緩剤市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・中枢作用性筋弛緩剤、末梢作用性筋弛緩剤

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Amneal Pharmaceuticals LLC、lpsen Biopharmaceuticals,Inc.、Merz Pharmaceuticals,LLC.、ParPharmaceutical、Endo Pharmaceuticals、Vertical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai、MetacelPharmaceuticals, LLC.、TevaPharmaceuticals USA、Pfizer、Novartis AG,、Johnson & Johnson、Merck & Co., Inc.、Eli Lilly and Company

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、筋弛緩剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な筋弛緩剤メーカーの企業概要、2019年~2022年までの筋弛緩剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な筋弛緩剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別筋弛緩剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの筋弛緩剤のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での筋弛緩剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および筋弛緩剤の産業チェーンを掲載しています。
・第14、15章では、筋弛緩剤の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 筋弛緩剤の概要
– タイプ別分析(2018年vs2022年vs2029年):中枢作用性筋弛緩剤、末梢作用性筋弛緩剤
– 用途別分析(2018年vs2022年vs2029年):病院薬局、小売薬局、オンライン薬局
– 世界の筋弛緩剤市場規模・予測
– 世界の筋弛緩剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Amneal Pharmaceuticals LLC、lpsen Biopharmaceuticals,Inc.、Merz Pharmaceuticals,LLC.、ParPharmaceutical、Endo Pharmaceuticals、Vertical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai、MetacelPharmaceuticals, LLC.、TevaPharmaceuticals USA、Pfizer、Novartis AG,、Johnson & Johnson、Merck & Co., Inc.、Eli Lilly and Company
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:中枢作用性筋弛緩剤、末梢作用性筋弛緩剤
・用途別分析2018年-2029年:病院薬局、小売薬局、オンライン薬局
・筋弛緩剤の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・筋弛緩剤のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・筋弛緩剤のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・筋弛緩剤の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・筋弛緩剤の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Muscle Relaxant Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Muscle Relaxant Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Centrally Acting Muscle Relaxants
1.3.3 Peripherally Acting Muscle Relaxants
1.4 Market Analysis by Application
1.4.1 Overview: Global Muscle Relaxant Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Muscle Relaxant Drug Market Size & Forecast
1.5.1 Global Muscle Relaxant Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Muscle Relaxant Drug Sales Quantity (2018-2029)
1.5.3 Global Muscle Relaxant Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Amneal Pharmaceuticals LLC
2.1.1 Amneal Pharmaceuticals LLC Details
2.1.2 Amneal Pharmaceuticals LLC Major Business
2.1.3 Amneal Pharmaceuticals LLC Muscle Relaxant Drug Product and Services
2.1.4 Amneal Pharmaceuticals LLC Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.2 lpsen Biopharmaceuticals,Inc.
2.2.1 lpsen Biopharmaceuticals,Inc. Details
2.2.2 lpsen Biopharmaceuticals,Inc. Major Business
2.2.3 lpsen Biopharmaceuticals,Inc. Muscle Relaxant Drug Product and Services
2.2.4 lpsen Biopharmaceuticals,Inc. Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 lpsen Biopharmaceuticals,Inc. Recent Developments/Updates
2.3 Merz Pharmaceuticals,LLC.
2.3.1 Merz Pharmaceuticals,LLC. Details
2.3.2 Merz Pharmaceuticals,LLC. Major Business
2.3.3 Merz Pharmaceuticals,LLC. Muscle Relaxant Drug Product and Services
2.3.4 Merz Pharmaceuticals,LLC. Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merz Pharmaceuticals,LLC. Recent Developments/Updates
2.4 ParPharmaceutical
2.4.1 ParPharmaceutical Details
2.4.2 ParPharmaceutical Major Business
2.4.3 ParPharmaceutical Muscle Relaxant Drug Product and Services
2.4.4 ParPharmaceutical Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ParPharmaceutical Recent Developments/Updates
2.5 Endo Pharmaceuticals
2.5.1 Endo Pharmaceuticals Details
2.5.2 Endo Pharmaceuticals Major Business
2.5.3 Endo Pharmaceuticals Muscle Relaxant Drug Product and Services
2.5.4 Endo Pharmaceuticals Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Endo Pharmaceuticals Recent Developments/Updates
2.6 Vertical Pharmaceuticals
2.6.1 Vertical Pharmaceuticals Details
2.6.2 Vertical Pharmaceuticals Major Business
2.6.3 Vertical Pharmaceuticals Muscle Relaxant Drug Product and Services
2.6.4 Vertical Pharmaceuticals Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Vertical Pharmaceuticals Recent Developments/Updates
2.7 Mallinckrodt
2.7.1 Mallinckrodt Details
2.7.2 Mallinckrodt Major Business
2.7.3 Mallinckrodt Muscle Relaxant Drug Product and Services
2.7.4 Mallinckrodt Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mallinckrodt Recent Developments/Updates
2.8 SteriMax
2.8.1 SteriMax Details
2.8.2 SteriMax Major Business
2.8.3 SteriMax Muscle Relaxant Drug Product and Services
2.8.4 SteriMax Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 SteriMax Recent Developments/Updates
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Muscle Relaxant Drug Product and Services
2.9.4 Eisai Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eisai Recent Developments/Updates
2.10 MetacelPharmaceuticals, LLC.
2.10.1 MetacelPharmaceuticals, LLC. Details
2.10.2 MetacelPharmaceuticals, LLC. Major Business
2.10.3 MetacelPharmaceuticals, LLC. Muscle Relaxant Drug Product and Services
2.10.4 MetacelPharmaceuticals, LLC. Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MetacelPharmaceuticals, LLC. Recent Developments/Updates
2.11 TevaPharmaceuticals USA
2.11.1 TevaPharmaceuticals USA Details
2.11.2 TevaPharmaceuticals USA Major Business
2.11.3 TevaPharmaceuticals USA Muscle Relaxant Drug Product and Services
2.11.4 TevaPharmaceuticals USA Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 TevaPharmaceuticals USA Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Muscle Relaxant Drug Product and Services
2.12.4 Pfizer Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Novartis AG,
2.13.1 Novartis AG, Details
2.13.2 Novartis AG, Major Business
2.13.3 Novartis AG, Muscle Relaxant Drug Product and Services
2.13.4 Novartis AG, Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Novartis AG, Recent Developments/Updates
2.14 Johnson & Johnson
2.14.1 Johnson & Johnson Details
2.14.2 Johnson & Johnson Major Business
2.14.3 Johnson & Johnson Muscle Relaxant Drug Product and Services
2.14.4 Johnson & Johnson Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Johnson & Johnson Recent Developments/Updates
2.15 Merck & Co., Inc.
2.15.1 Merck & Co., Inc. Details
2.15.2 Merck & Co., Inc. Major Business
2.15.3 Merck & Co., Inc. Muscle Relaxant Drug Product and Services
2.15.4 Merck & Co., Inc. Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Merck & Co., Inc. Recent Developments/Updates
2.16 Eli Lilly and Company
2.16.1 Eli Lilly and Company Details
2.16.2 Eli Lilly and Company Major Business
2.16.3 Eli Lilly and Company Muscle Relaxant Drug Product and Services
2.16.4 Eli Lilly and Company Muscle Relaxant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Eli Lilly and Company Recent Developments/Updates
3 Competitive Environment: Muscle Relaxant Drug by Manufacturer
3.1 Global Muscle Relaxant Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Muscle Relaxant Drug Revenue by Manufacturer (2018-2023)
3.3 Global Muscle Relaxant Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Muscle Relaxant Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Muscle Relaxant Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Muscle Relaxant Drug Manufacturer Market Share in 2022
3.5 Muscle Relaxant Drug Market: Overall Company Footprint Analysis
3.5.1 Muscle Relaxant Drug Market: Region Footprint
3.5.2 Muscle Relaxant Drug Market: Company Product Type Footprint
3.5.3 Muscle Relaxant Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Muscle Relaxant Drug Market Size by Region
4.1.1 Global Muscle Relaxant Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Muscle Relaxant Drug Consumption Value by Region (2018-2029)
4.1.3 Global Muscle Relaxant Drug Average Price by Region (2018-2029)
4.2 North America Muscle Relaxant Drug Consumption Value (2018-2029)
4.3 Europe Muscle Relaxant Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Muscle Relaxant Drug Consumption Value (2018-2029)
4.5 South America Muscle Relaxant Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Muscle Relaxant Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
5.2 Global Muscle Relaxant Drug Consumption Value by Type (2018-2029)
5.3 Global Muscle Relaxant Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
6.2 Global Muscle Relaxant Drug Consumption Value by Application (2018-2029)
6.3 Global Muscle Relaxant Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
7.2 North America Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
7.3 North America Muscle Relaxant Drug Market Size by Country
7.3.1 North America Muscle Relaxant Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Muscle Relaxant Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
8.2 Europe Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
8.3 Europe Muscle Relaxant Drug Market Size by Country
8.3.1 Europe Muscle Relaxant Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Muscle Relaxant Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Muscle Relaxant Drug Market Size by Region
9.3.1 Asia-Pacific Muscle Relaxant Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Muscle Relaxant Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
10.2 South America Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
10.3 South America Muscle Relaxant Drug Market Size by Country
10.3.1 South America Muscle Relaxant Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Muscle Relaxant Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Muscle Relaxant Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Muscle Relaxant Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Muscle Relaxant Drug Market Size by Country
11.3.1 Middle East & Africa Muscle Relaxant Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Muscle Relaxant Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Muscle Relaxant Drug Market Drivers
12.2 Muscle Relaxant Drug Market Restraints
12.3 Muscle Relaxant Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Muscle Relaxant Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Muscle Relaxant Drug
13.3 Muscle Relaxant Drug Production Process
13.4 Muscle Relaxant Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Muscle Relaxant Drug Typical Distributors
14.3 Muscle Relaxant Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Muscle Relaxant Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Muscle Relaxant Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 4. Amneal Pharmaceuticals LLC Major Business
Table 5. Amneal Pharmaceuticals LLC Muscle Relaxant Drug Product and Services
Table 6. Amneal Pharmaceuticals LLC Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 8. lpsen Biopharmaceuticals,Inc. Basic Information, Manufacturing Base and Competitors
Table 9. lpsen Biopharmaceuticals,Inc. Major Business
Table 10. lpsen Biopharmaceuticals,Inc. Muscle Relaxant Drug Product and Services
Table 11. lpsen Biopharmaceuticals,Inc. Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. lpsen Biopharmaceuticals,Inc. Recent Developments/Updates
Table 13. Merz Pharmaceuticals,LLC. Basic Information, Manufacturing Base and Competitors
Table 14. Merz Pharmaceuticals,LLC. Major Business
Table 15. Merz Pharmaceuticals,LLC. Muscle Relaxant Drug Product and Services
Table 16. Merz Pharmaceuticals,LLC. Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merz Pharmaceuticals,LLC. Recent Developments/Updates
Table 18. ParPharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. ParPharmaceutical Major Business
Table 20. ParPharmaceutical Muscle Relaxant Drug Product and Services
Table 21. ParPharmaceutical Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. ParPharmaceutical Recent Developments/Updates
Table 23. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Endo Pharmaceuticals Major Business
Table 25. Endo Pharmaceuticals Muscle Relaxant Drug Product and Services
Table 26. Endo Pharmaceuticals Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Endo Pharmaceuticals Recent Developments/Updates
Table 28. Vertical Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Vertical Pharmaceuticals Major Business
Table 30. Vertical Pharmaceuticals Muscle Relaxant Drug Product and Services
Table 31. Vertical Pharmaceuticals Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Vertical Pharmaceuticals Recent Developments/Updates
Table 33. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 34. Mallinckrodt Major Business
Table 35. Mallinckrodt Muscle Relaxant Drug Product and Services
Table 36. Mallinckrodt Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mallinckrodt Recent Developments/Updates
Table 38. SteriMax Basic Information, Manufacturing Base and Competitors
Table 39. SteriMax Major Business
Table 40. SteriMax Muscle Relaxant Drug Product and Services
Table 41. SteriMax Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. SteriMax Recent Developments/Updates
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Major Business
Table 45. Eisai Muscle Relaxant Drug Product and Services
Table 46. Eisai Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Eisai Recent Developments/Updates
Table 48. MetacelPharmaceuticals, LLC. Basic Information, Manufacturing Base and Competitors
Table 49. MetacelPharmaceuticals, LLC. Major Business
Table 50. MetacelPharmaceuticals, LLC. Muscle Relaxant Drug Product and Services
Table 51. MetacelPharmaceuticals, LLC. Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MetacelPharmaceuticals, LLC. Recent Developments/Updates
Table 53. TevaPharmaceuticals USA Basic Information, Manufacturing Base and Competitors
Table 54. TevaPharmaceuticals USA Major Business
Table 55. TevaPharmaceuticals USA Muscle Relaxant Drug Product and Services
Table 56. TevaPharmaceuticals USA Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. TevaPharmaceuticals USA Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Muscle Relaxant Drug Product and Services
Table 61. Pfizer Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Novartis AG, Basic Information, Manufacturing Base and Competitors
Table 64. Novartis AG, Major Business
Table 65. Novartis AG, Muscle Relaxant Drug Product and Services
Table 66. Novartis AG, Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Novartis AG, Recent Developments/Updates
Table 68. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 69. Johnson & Johnson Major Business
Table 70. Johnson & Johnson Muscle Relaxant Drug Product and Services
Table 71. Johnson & Johnson Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Johnson & Johnson Recent Developments/Updates
Table 73. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co., Inc. Major Business
Table 75. Merck & Co., Inc. Muscle Relaxant Drug Product and Services
Table 76. Merck & Co., Inc. Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck & Co., Inc. Recent Developments/Updates
Table 78. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 79. Eli Lilly and Company Major Business
Table 80. Eli Lilly and Company Muscle Relaxant Drug Product and Services
Table 81. Eli Lilly and Company Muscle Relaxant Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Eli Lilly and Company Recent Developments/Updates
Table 83. Global Muscle Relaxant Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Muscle Relaxant Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Muscle Relaxant Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Muscle Relaxant Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Muscle Relaxant Drug Production Site of Key Manufacturer
Table 88. Muscle Relaxant Drug Market: Company Product Type Footprint
Table 89. Muscle Relaxant Drug Market: Company Product Application Footprint
Table 90. Muscle Relaxant Drug New Market Entrants and Barriers to Market Entry
Table 91. Muscle Relaxant Drug Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Muscle Relaxant Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Muscle Relaxant Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Muscle Relaxant Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Muscle Relaxant Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Muscle Relaxant Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Muscle Relaxant Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Muscle Relaxant Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Muscle Relaxant Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Muscle Relaxant Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Muscle Relaxant Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Muscle Relaxant Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Muscle Relaxant Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Muscle Relaxant Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Muscle Relaxant Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Muscle Relaxant Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Muscle Relaxant Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Muscle Relaxant Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Muscle Relaxant Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Muscle Relaxant Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Muscle Relaxant Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Muscle Relaxant Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Muscle Relaxant Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Muscle Relaxant Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Muscle Relaxant Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Muscle Relaxant Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Muscle Relaxant Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Muscle Relaxant Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Muscle Relaxant Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Muscle Relaxant Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Muscle Relaxant Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Muscle Relaxant Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Muscle Relaxant Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Muscle Relaxant Drug Raw Material
Table 151. Key Manufacturers of Muscle Relaxant Drug Raw Materials
Table 152. Muscle Relaxant Drug Typical Distributors
Table 153. Muscle Relaxant Drug Typical Customers
List of Figures
Figure 1. Muscle Relaxant Drug Picture
Figure 2. Global Muscle Relaxant Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Muscle Relaxant Drug Consumption Value Market Share by Type in 2022
Figure 4. Centrally Acting Muscle Relaxants Examples
Figure 5. Peripherally Acting Muscle Relaxants Examples
Figure 6. Global Muscle Relaxant Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Muscle Relaxant Drug Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Muscle Relaxant Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Muscle Relaxant Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Muscle Relaxant Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Muscle Relaxant Drug Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Muscle Relaxant Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Muscle Relaxant Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Muscle Relaxant Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Muscle Relaxant Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Muscle Relaxant Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Muscle Relaxant Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Muscle Relaxant Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Muscle Relaxant Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Muscle Relaxant Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Muscle Relaxant Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Muscle Relaxant Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Muscle Relaxant Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Muscle Relaxant Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Muscle Relaxant Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Muscle Relaxant Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Muscle Relaxant Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Muscle Relaxant Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Muscle Relaxant Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Muscle Relaxant Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Muscle Relaxant Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Muscle Relaxant Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Muscle Relaxant Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Muscle Relaxant Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Muscle Relaxant Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Muscle Relaxant Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Muscle Relaxant Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Muscle Relaxant Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Muscle Relaxant Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Muscle Relaxant Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Muscle Relaxant Drug Market Drivers
Figure 74. Muscle Relaxant Drug Market Restraints
Figure 75. Muscle Relaxant Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Muscle Relaxant Drug in 2022
Figure 78. Manufacturing Process Analysis of Muscle Relaxant Drug
Figure 79. Muscle Relaxant Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


★調査レポート[世界の筋弛緩剤市場2023年:企業・地域・タイプ・用途別分析] (コード:GIR23AG11474)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の筋弛緩剤市場2023年:企業・地域・タイプ・用途別分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆